Method for identifying whether a patient will be responder or not to immunotherapy

Details for Australian Patent Application No. 2007256383 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Gruselle, Olivier; Clark, James Scott; Gaulis, Swann Romain Jean-Thomas; Brichard, Vincent; Lehmann, Frederic; Louahed, Jamila; Coche, Thierry

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007256383

PCT Pub. Number WO2007/140958

Priority 0700761.0 15.01.07 GB; 0610949.0 02.06.06 GB

Filing date 31 May 2007

Wipo publication date 13 December 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/140958 Priority application(s): WO2007/140958

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007256384-Oral hygiene device

2007256377-Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma